Market revenue in 2023 | USD 321.0 million |
Market revenue in 2030 | USD 572.8 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care |
Key market players worldwide | Abbott Laboratories, BioMerieux SA, QuidelOrtho Corp, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Qiagen NV, Sysmex Corp, Charles River Laboratories International Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Danaher Corp, Becton Dickinson & Co, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to coagulation market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 42.55% in 2023. Horizon Databook has segmented the China coagulation market based on hospitals, outpatient facilities, home care covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the China coagulation market , including forecasts for subscribers. This country databook contains high-level insights into China coagulation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account